FertiLife

Hi, I am Pr. Jean Philippe Wolf Head of the department of biology of reproduction in Cochin Hospital, future CEO and Founder of FertiLife sas

Having a baby is the wish of millions of couples, but women fertility decreases with  age and with the ovocyte quality. At 35 women fertility is critical. At 37 it drops. At 40 its finished. This is why Assisted Reproductive Technologies (ART) are booming, and more than a million attempts are performed every year world wide.

It is more and more efficient but It remains stressful, desperately long and horribly expensive (between 10 and 50 K€ per attempt).

To create a breakthrough on this demanding market, we need to improve ovocyte quality. Ovocyte quality is the new frontier !

Fertiline peptide, our first product, is a fantastic drug enhancing the ovocyte quality and restoring its metabolism of energy

Fertiline improves ART outcomes reducing the number of miscarriages by 50%, it reduces the number of attempt, bringing new babies in perfect health to the expecting parents faster.

Producing this drug is not complicated. We already have succesful animal data, a  very promizing first clinical randomized trial in human and have secured the intellectual property on Fertiline worldwide.

We are founding a start-up to achieve the development of Fertiline, to register and commercialize it from 2020 onwards.

We are raising 1.5 million euros and looking for partner interested in co-development and commercialization